Dysregulated Ribosome Biogenesis Is a Targetable Vulnerability in Triple-Negative Breast Cancer: MRPS27 as a Key Mediator of the Stemness-inhibitory Effect of Lovastatin
Chanjuan Zheng(Hunan Normal University), Xiyun Deng(Hunan Normal University), Zhongyi Cheng(New England Biolabs (China)), Evan T. Keller(University of Michigan), Shujun Fu(Hunan Normal University), Guangchun He(Hunan Normal University), Suling Liu(Shanghai Medical College of Fudan University), Sisi Chen(Hunan Normal University), Xinyu Wang(Hunan Normal University), Hui Yao(Agricultural Genomics Institute at Shenzhen), Lei Zhou(Fudan University), Xi Xu(Hunan Normal University), Hongzhuo Xia(Hunan Normal University), Hongqi Li(Fudan University), Lian Xue(Hunan Normal University), Xiaojun Peng(New England Biolabs (China)), Xueyan He(Fudan University), Lu Lu(Fudan University), Muyao Wu(Hunan Normal University), Yian Wang(Hunan Normal University), Siyu Ding(Hunan Normal University), Yiyuan Yang(Hunan Normal University), Yi‐Zhou Jiang(Shanghai Medical College of Fudan University)
Cited by 7
Related Papers
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
|Cell|2006|1.4k
The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)
|The Lancet|2017|856
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells
|Emerging Microbes & Infections|2021|474
Mammary stem cells, self-renewal pathways, and carcinogenesis
|Breast Cancer Research|2005|443